Pharmaceutical Business Review
Drug Discovery & Development
Anonymous User | Login

Cerus, Grifols Collaborate For Red Blood Cell Treatment

Published: 02-Jun-2009

Grifols to provide technical expertise and resources for the development of commercial kit manufacturing

Cerus, and a subsidiary of Grifols have announced that the two companies have entered into an agreement to collaborate on the development of red blood cell treatment sets for use in the Intercept Blood System.

Under this agreement, Grifols has to provide their technical expertise and resources for the development of commercial kit manufacturing, and also establishes joint commitment to a future commercial manufacturing contract.

The Intercept red blood cell system, currently in phase I trials, is being developed to inactivate a broad range of pathogens expected to contaminate donated blood.

Claes Glassell, President and CEO of Cerus Corporation, said: “Grifols’ demonstrated expertise in blood collection sets is a significant asset to the Intercept red cell program.”

Albert Grifols, General Manager of Laboratorios Grifols, said: “We are pleased to further strengthen our relationship with Cerus after our success with the Intercept platelet system.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Vetter Pharma International

High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...

Turku Region

A Bright Future in a Great Location ...

TNO

Pharma Services: From Discovery to the Clinic ...

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

Thermo Fisher Scientific

The world leader in serving science ...

Tecnosoft

Monitoring Systems for Temperature, Humidity and Pressure ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Your IP at Risk in Collaborations!

Free white paper: Ten steps to protect your R&D investment within partnerships. ...

Why, When and How to Conduct 14C Human Studies

Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...

Why CAPA Still Matters

This free white paper explores the needs and effectiveness of correct CAPA control, how to ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly

Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Related Companies

Corgenix Medical Corporation

Corgenix Medical Corporation (Corgenix) is a diagnostic company engaged in research, de ...

Gen-Probe Incorporated

Gen-Probe Incorporated (Gen-Probe) is engaged in the development, manufacture and marke ...

Cerus Corporation

Cerus Corporation (Cerus) is a biopharmaceutical company engaged in the development and ...

Gen-Probe Incorporated

Gen-Probe Incorporated (Gen-Probe) is engaged in the development, manufacture and marke ...

Corgenix Medical Corporation

Corgenix Medical Corporation (Corgenix) is a diagnostic company engaged in research, de ...

Suppliers Product News

Vetter Dedicates New Facility in Suburban Chicago

The new facility will enable collaboration very early in development process

Pharma Supplier Vetter Shares Pride in Consistent Growth and International Success with Distinguished Visitor Minister zu Guttenberg

Economics and Technology Minister visits global leader's headquarters in southern Germany.

Vetter Packages Success with New Facility

Vetter's new secondary packaging operation allows the company to double its production in half the time.

Finland's Business Environment Ranked Best in the World

The authoritative Economist Intelligence Unit has ranked Finland's business environment as the best in the world for the period 2009-2013.

Finland is the World's Most Prosperous Nation

According to the latest Legatum Prosperity Index, the Finnish economy and society enjoy many of the factors that help drive economic growth and produce happy citizens over the long term. Published for the third time, the Legatum Prosperity Index rates more than 100 nations worldwide according to how well they cultivate empirically-tested drivers of economic and social wellbeing.

Amarna Therapeutics B.V. and TNO Announce SVac Research and Development Partnership

Dutch biotechnology company Amarna Therapeutics B.V. and the Netherlands Organisation for Applied Scientific Research TNO today announced that they have entered into a collaboration agreement to further develop Amarna's viral gene delivery platform SVac.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address